Catheter-based therapy for atherosclerotic renal artery stenosis

Circulation

Volumn 113, Issue 11, 2006, Pages 1464-1473

  White, Christopher J ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Angioplasty; Hypertension; Kidney; Renin; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; CLOPIDOGREL; CREATININE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; RENIN; BRAIN NATRIURETIC PEPTIDE;

ANGIOCARDIOGRAPHY; ARTERY CATHETER; ARTERY CATHETERIZATION; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DIAGNOSTIC IMAGING; DRUG USE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE OVERLOAD; HUMAN; IMAGE ANALYSIS; INTRAVASCULAR ULTRASOUND; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MAGNETIC RESONANCE ANGIOGRAPHY; NEPHROSCLEROSIS; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLASMA RENIN ACTIVITY; PREDICTION; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; SCREENING; STENT; AGED; ARTERIOSCLEROSIS; BLOOD; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; EMBOLISM; FEMALE; HEART DISEASE; LUNG EDEMA; MALE; MASS SCREENING; META ANALYSIS; METHODOLOGY; MIDDLE AGED; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; STATISTICS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; DIAGNOSTIC IMAGING; EMBOLISM; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION, RENOVASCULAR; MALE; MASS SCREENING; META-ANALYSIS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREVALENCE; PULMONARY EDEMA; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RENAL ARTERY OBSTRUCTION; STENTS; TREATMENT OUTCOME;

EID: 33645830487     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.540039     Document Type: Article

References (86)

1. Garovic V, Textor SC. Renovascular hypertension: current concepts. Semin Nephrol. 2005;25:261-271.
2. Garovic VD. Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation. 2005;112:1362-1374.
3. Conlon PJ, Athirakul K, Kovalik E, Schwab SJ, Crowley J, Stack R, McCants CB Jr, Mark DB, Bashore TM, Albers F. Survival in renal vascular disease. J Am Soc Nephrol. 1998;9:252-256.
4. Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60:1490-1497.
5. Kennedy DJ, Colyer WR, Brewster PS, Ankenbrandt M, Burket MW, Nemeth AS, Khuder SA, Thomas WJ, Shapiro JI, Cooper CJ. Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis. 2003;42:926-935.
6. Babb JD, Collins TJ, Cowley MJ, Dorros G, Freedman RJ Jr, Galichia J, Iannone IA, Kern MJ, Tommaso CL, Ramee SR, Rosenfield K, Roubin GS, Weintraub RA, White RA, White CJ. Revised guidelines for the performance of peripheral vascular intervention. Catheter Cardiovasc Interv. 1999;46:21-23.
7. Creager MA, Goldstone J, Hirshfeld JW Jr, Kazmers A, Kent KC, Lorell BH, Olin JW, Rainer Pauly R, Rosenfield K, Roubin GS, Sicard GA, White CJ, Winters WL Jr, Merli G, Rodgers GP, Tracy CM, Weitz HH. ACC/ACP/SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/ American College of Physician Task Force on Clinical Competence (ACC/ACP/SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on peripheral vascular disease). J Am Coll Cardiol. 2004;44:941-957.
8. Beller GA, Bonow RO, Fuster V. ACC revised recommendations for training in adult cardiovascular medicine: Core Cardiology Training II (COCATS 2). (Revision of the 1995 COCATS training statement). J Am Coll Cardiol. 2002;39:1242-1246.
9. Murphy TP, Soares G, Kim M. Increase in utilization of percutaneous renal artery interventions by medicare beneficiaries, 1996-2000. AJR Am J Roentgenol. 2004;183:561-568.
10. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36:443-451.
11. Holley KE, Hunt JC, Brown AL Jr, Kincaid OW, Sheps SG. Renal artery stenosis: a clinical-pathologic study in normotensive and hypertensive patients. Am J Med. 1964;37:14-22.
12. Meaney T, Dustan H, McCormack L. Natural history of renal arterial disease. Radiology. 1968;91:881-887.
13. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-442.
14. Aqel RA, Zoghbi GJ, Baldwin SA, Auda WS, Calhoun DA, Coffey CS, Perry GJ, Iskandrian AE. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. J Hypertens. 2003;21:1157-1162.
15. Weber-Mzell D, Kotanko P, Schumacher M, Klein W, Skrabal F. Coronary anatomy predicts presence or absence of renal artery stenosis: a prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J. 2002;23:1684-1691.
16. Rihal CS, Textor SC, Breen JF, McKusick MA, Grill DE, Hallet JW, Holmes DR Jr. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002;77:309-316.
17. Vetrovec GW, Landwehr DM, Edwards VI. Incidence of renal artery stenosis in hypertensive patients undergoing coronary angiography. J Interv Cardiol. 1989;2:69-76.
18. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, Hermiller JB, Davidson CJ, Bashore TM. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2:1608-1616.
19. Jean WJ, Al-Bitar I, Zwicke DL, Port SC, Schmidt DH, Bajwa TK. High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn. 1994;32:8-10.
20. Olin J, Melia M, Young J, Graor R, Risius B. Prevalence of atherosclerosis renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88:46N-51N.
21. Valentine R, Myers S, Miller G, Lopez M, Clagett G. Detection of unsuspected renal artery stenoses in patients with abdominal aortic aneurysms: refined indicants for preoperative aortography. Ann Vasc Surg. 1993;7:220-224.
22. Schwartz CJ, White TA. Stenosis of renal artery: an unselected necropsy study. BMJ. 1964;5422:1415-1421.
23. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984;11:383-392.
24. Crowley J, Santos R, Peter R, Puma J, Schwab S, Phillips H, Stack R, Conlon P. Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J. 1998;136:913-918.
25. Dean R, Kieffer R, Smith B, Oates J, Nadeau J, Hollifield J, DuPont W. Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg. 1981;116:1408-1415.
26. Caps M, Perissinotto C, Zierler R, Polissar N, Bergelin R, Tullis M, Cantwell-Gab K, Davidson R, Strandness DJ. Prospective study of atherosclerotic disease progression in the renal artery. Circulation. 1998;98:2866-2872.
27. van Jaarsveld B, Krijnen P, Pieterman H, Derkx F, Deinum J, Postma C, Dees A, Woittiez A, Bartelink A, Man in 't Veld A, Schalekamp M. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. N Engl J Med. 2000;342:1007-1014.
28. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med. 1993;118:712-719.
29. Scoble JE, Maher ER, Hamilton G, Dick R, Sweny P, Moorhead JF. Atherosclerotic renovascular disease causing renal impairment: a case for treatment. Clin Nephrol. 1989;31:119-122.
30. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis. 1994;24:622-629.
31. Olin J, Piedmonte M, Young J, DeAnna S, Grubb M, Childs M. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med. 1995;122:833-838.
32. Bolduc JP, Oliva VL, Therasse E, Giroux MF, Bouchard L, Perreault P, Cliche A, Soulez G. Diagnosis and treatment of renovascular hypertension: a cost-benefit analysis. AJR Am J Roentgenol. 2005;184:931-937.
33. Olbricht CJ, Paul K, Prokop M, Chavan A, Schaefer-Prokop CM, Jandeleit K, Koch KM, Galanski M. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int. 1995;48:1332-1337.
34. Jurgen J, Wildermuth S, Pfammatter T, Roos J, Selfert B, Jilfiker P, Marincek B, Weshaupt D. Aortoiliac and renal arteries: prospective intraindividual comparison of contrast-enhanced three-dimensional MR angiography and multi-detector row CT angiography. Radiology. 2003;226:798-811.
35. Huot S, Hansson J, Dey H, Concato J. Utility of captopril renal scans for detecting renal artery stenosis. Arch Intern Med. 2002;162:1981-1984.
36. Rundback JH, Sacks D, Kent KC, Cooper C, Jones D, Murphy T, Rosenfield K, White C, Bettmann M, Cortell S, Puschett J, Clair D, Cole P. Guidelines for the reporting of renal artery revascularization in clinical trials: American Heart Association. Circulation 2002;106:1572-1585.
37. Leertouwer TC, Gussenhoven EJ, Bosch JL, van Jaarsveld BC, van Dijk LC, Deinum J, Man In 't Veld AJ. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000;216:78-85.
38. Chrysant GS, Goldstein JA, Casserly IP, Rogers JH, Kurz HI, Thorstad WL, Singh J, Lasala JM. Endovascular brachytherapy for treatment of bilateral renal artery in-stent restenosis. Catheter Cardiovasc Interv. 2003;59:251-254.
39. Subramanian R, White CJ, Rosenfield K, Bashir R, Almagor Y, Meerkin D, Shalman E. Renal fractional flow reserve: a hemodynamic evaluation of moderate renal artery stenoses. Catheter Cardiovasc Interv. 2005;64:480-486.
40. Mitchell J, Subramanian R, Stewart R, White C. Pressure-derived renal fractional flow reserve with clinical outcomes following intervention. Catheter Cardiovasc Interv. 2005;65:135. Abstract.
41. Martinez-Maldonado M. Pathophysiology of renovascular hypertension. Hypertension. 1991;17:707-719.
42. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inouye K, Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-1412.
43. Lai KN, Leung JC, Yandle TG, Fisher S, Nicholls MG. Gene expression and synthesis of natriuretic peptides by cultured human glomerular cells. J Hypertens. 1999;17:575-583.
44. Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmidt-Schweda S, Fuchtbauer EM, Dohrmann U, Beyersdorf F, Radicke D, Holubarsch CJ. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation. 2000;102:3074-3079.
45. Wolf K, Kurtz A, Pfeifer M, Hocherl K, Riegger GA, Kramer BK. Different regulation of left ventricular ANP, BNP and adrenomedullin mRNA in the two-kidney, one-clip model of renovascular hypertension. Pflugers Arch. 2001;442:212-217.
46. Silva JA, Chan AW, White CJ, Coffins TJ, Jenkins JS, Reilly JP, Ramee SR. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation. 2005;111:328-333.
47. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel M, Galanski M, Koch K, Haller H. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344:410-417.
48. Zeller T, Muller C, Frank U, Burgelin K, Horn B, Schwarzwalder U, Cook-Bruns N, Neumann F. Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis. Catheter Cardiovasc Interv. 2003;58:510-515.
49. Zeller T, Frank U, Muller C, Burgelin K, Sinn L, Bestehorn HP, Cook-Bruns N, Neumann F. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108:2244-2249.
50. Muray S, Martin M, Amoedo M, Garcia C, Jornet A, Vera M, Oliverae A, Gomez X, Graver L, Real M, Garcia L, Botey A, Montanya X, Fernandez E. Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis. 2002;39:60-66.
51. Harden P, MacLeod M, Rodger R, Baxter G, Connell J, Dominiczak A, Junor B, Briggs J, Moss J. Effect of renal artery stenting on progression of renovascular renal failure. Lancet. 1997;349:1133-1136.
52. Watson P, Hadjipetrou P, Cox S, Piemonte T, Eisenhauer A. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000;102:1671-1677.
53. Leertouwer TC, Derkx FH, Pattynama PM, Deinum J, van Dijk LC, Schalekamp MA. Functional effects of renal artery stent placement on treated and contralateral kidneys. Kidney Int. 2002;62:574-579.
54. La Batide-Alanore A, Azizi M, Froissart M, Raynaud A, Plouin PF. Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis. J Am Soc Nephrol. 2001;12:1235-1241.
55. Gray BH, Olin JW, Childs MB, Sullivan TM, Bacharach JM. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med. 2002;7:275-279.
56. Azizi M, Lavergne T, Day M, Pauly-Laubry C, Plouin PF. Renal artery stenosis and congestive heart failure. Lancet. 1993;342:302.
57. Khosla S, White CJ, Coffins TJ, Jenkins JS, Shaw D, Ramee SR. Effects of renal artery stent implantation in patients with renovascular hypertension presenting with unstable angina or congestive heart failure. Am J Cardiol. 1997;80:363-366.
58. Mwipatayi BP, Beningfield SJ, White LE, Irish A, Abbas M, Sieunarine K. A review of the current treatment of renal artery stenosis. Eur J Vasc Endovasc Surg. 2005;29:479-488.
59. Sekkarie M. Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent. Am J Kidney Dis. 1999;33:613-614.
60. Burket M, Cooper C, Kennedy D, Brewster P, Ansel G, Moore J, Venkatesan J, Henrich W. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J. 2000;139:64-71.
61. Dorros G, Jaff M, Mathiak L, Dorros II, Lowe A, Murphy K, He T. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642-647.
62. Rocha-Singh KJ, Mishkel GJ, Katholi RE, Ligon RA, Armbruster JA, McShane KJ, Zeck KJ. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Catheter Cardiovasc Interv. 1999;47:167-172.
63. White CJ, Ramee SR, Coffins TJ, Jenkins JS, Escobar A, Shaw D. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol. 1997;30:1445-1450.
64. Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG, Loose H, Main J, Padfield P, Russell IT, Walker B, Watson M, Wilkinson R. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis: Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens. 1998;12:329-335.
65. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial: Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823-829.
66. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004;350:1862-1871.
67. Sos T, Pickering T, Sniderman K, Saddekni S, Case D, Silane M, Vaughan E, Laragh J. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med. 1983;309:274-279.
68. Plouin P, Darne B, Chattelier G, Pannier I, Battaglia C, Raynaud A, Azizi M. Restenosis after a first transluminal percutaneous renal angioplasty. Hypertension. 1993;21:89-96.
69. Dorros G, Prince C, Mathiak L. Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Cathet Cardiovasc Diagn. 1993;29:191-198.
70. van de Ven PJ, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E, Koomans HA, Mali WP. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353:282-286.
71. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. Q J Med. 1999;92:159-167.
72. Blum U, Krumme B, Flugel P, Gabelmann A, Lehnert T, Buitrago-Tellez C, Schollmeyer P, Langer M. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty [see comments]. N Engl J Med. 1997;336:459-465.
73. Henry M, Amor M, Henry I, Ethevenot G, Tzvetanov K, Courvoisier A, Mentre B, Chati Z. Stents in the treatment of renal artery stenosis: long-term follow-up. J Endovasc Surg. 1999;6:42-51.
74. Lederman R, Mendelsohn F, Santos R, Phillips H, Stack R, Crowley J. Primary renal artery stenting: characteristics and outcomes after 363 procedure. Am Heart J. 2001;142:314-323.
75. Nolan BW, Schermerhom ML, Powell RJ, Rowell E, Fillinger MF, Rzucidlo EM, Wyers MC, Whittaker D, Zwolak RM, Walsh DB, Cronenwett JL. Restenosis in gold-coated renal artery stents. J Vasc Surg. 2005;42:40-46.
76. Al-Mubarak N, Roubin GS, Vitek JJ, Iyer SS, New G, Leon MB. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation. 2001;104:1999-2002.
77. Scoble JE. Do protection devices have a role in renal angioplasty and stent placement? Nephrol Dial Transplant. 2003;18:1700-1703.
78. Henry M, Henry I, Klonaris C, Polydorou A, Rath P, Lakshmi G, Rajacopal S, Hugel M. Renal angioplasty and stenting under protection: the way for the future? Catheter Cardiovasc Interv. 2003;60:299-312.
79. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg. 2003;38:962-968.
80. Hagspiel KD, Stone JR, Leung DA. Renal angioplasty and stent placement with distal protection: preliminary experience with the FilterWire EX. J Vasc Interv Radiol. 2005;16:125-31.
81. Bax L, Mali WP, Van De Ven PJ, Beek FJ, Vos JA, Beutler JJ. Repeated intervention for in-stent restenosis of the renal arteries. J Vasc Interv Radiol. 2002;13:1219-1224.
82. Munneke GJ, Engelke C, Morgan RA, Belli AM. Cutting balloon angioplasty for resistant renal artery in-stent restenosis. J Vasc Interv Radiol. 2002;13:327-331.
83. Spratt JC, Leslie SJ, Verin V. A case of renal artery brachytherapy for in-stent restenosis: four-year follow-up. J Invasive Cardiol. 2004;16:287-288.
84. Ellis K, Murtagh B, Loghin C, Muench A, Boccalandro F, Go B, Ahmad M, Burjonroppa S, Rosales O, Smalling RW. The use of brachytherapy to treat renal artery in-stent restenosis. J Interv Cardiol. 2005;18:49-54.
85. Wohrle J, Kochs M, Vollmer C, Kestler HA, Hombach V, Hoher M. Re-angioplasty of in-stent restenosis versus balloon restenoses: a matched pair comparison. Int J Cardiol. 2004;93:257-262.
86. Granillo GA, van Dijk LC, McFadden EP, Serruys PW. Percutaneous radial intervention for complex bilateral renal artery stenosis using paclitaxel eluting stents. Catheter Cardiovasc Interv. 2005;64:23-27.